Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.

Mooser V, Nussberger J, Juillerat L, Burnier M, Waeber B, Bidiville J, Pauly N, Brunner HR.

J Cardiovasc Pharmacol. 1990 Feb;15(2):276-82.

PMID:
1689424
2.
3.

Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.

Waeber G, Beck G, Waeber B, Bidiville J, Nussberger J, Brunner HR.

J Hypertens. 1988 Mar;6(3):239-45.

PMID:
3283227
4.

Individual responses to converting enzyme inhibitors and calcium antagonists.

Bidiville J, Nussberger J, Waeber G, Porchet M, Waeber B, Brunner HR.

Hypertension. 1988 Feb;11(2):166-73.

PMID:
2830189
5.

Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.

Bidiville J, Waeber G, Porchet M, Nussberger J, Biollaz J, Gomez H, Callahan L, Waeber B, Brunner HR.

Fundam Clin Pharmacol. 1988;2(5):413-29.

PMID:
2976727
6.

Infusion of atrial natriuretic peptide to patients with congestive heart failure.

Goy JJ, Waeber B, Nussberger J, Bidiville J, Biollaz J, Nicod P, Mooser V, Kappenberger L, Brunner HR.

J Cardiovasc Pharmacol. 1988;12(5):562-70.

PMID:
2468056
7.

Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.

Mooser V, Waeber G, Bidiville J, Waeber B, Nussberger J, Brunner HR.

J Clin Hypertens. 1987 Dec;3(4):510-3.

PMID:
2839627
8.

Site of the action of a synthetic atrial natriuretic peptide evaluated in humans.

Biollaz J, Bidiville J, DiƩzi J, Waeber B, Nussberger J, Brunner-Ferber F, Gomez HJ, Brunner HR.

Kidney Int. 1987 Oct;32(4):537-46.

9.

Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording.

Waeber B, Scherrer U, Petrillo A, Bidiville J, Nussberger J, Waeber G, Hofstetter JR, Brunner HR.

Lancet. 1987 Sep 26;2(8561):732-4.

PMID:
2888953
10.

Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers.

Bidiville J, Porchet M, Bussien JP, Nussberger J, Waeber B, Brunner HR.

Arch Int Pharmacodyn Ther. 1987 Jul;288(1):109-19.

PMID:
2959228
11.

Pharmacodynamic and humoral effects of single intravenous doses of captopril in normal subjects.

Nussberger J, Waeber G, Bidiville J, Waeber B, Brunner HR.

Clin Exp Hypertens A. 1987;9(2-3):345-9.

PMID:
3301079
12.

Effect of prolonged angiotensin converting enzyme inhibition on ambulatory blood pressure of normotensive volunteers.

Bidiville J, Bussien JP, Porchet M, Nussberger J, Waeber B, Brunner HR.

Clin Exp Hypertens A. 1987;9(2-3):583-6.

PMID:
3038421
13.

Effect of human atrial natriuretic factor on renal plasma flow.

Bischof-Delaloye A, Bidiville J, Waeber B, Biollaz J, Gomez H, Delaloye B, Brunner HR.

Contrib Nephrol. 1987;56:12-7. No abstract available.

PMID:
2956057
14.

Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.

Brunner HR, Bidiville J, Waeber G, Porchet M, Nussberger J, Waeber B.

Nephron. 1987;47 Suppl 1:87-9.

PMID:
2827044
15.

Acute antihypertensive effect of angiotensin converting enzyme inhibition and calcium entry blockade.

Brunner HR, Nussberger J, Bidiville J, Waeber G, Porchet M, Waeber B.

J Cardiovasc Pharmacol. 1987;10 Suppl 10:S87-9.

PMID:
2455152
16.

[Effects of perfusion of human atrial natriuretic factor in normal volunteers].

Bidiville J, Waeber G, Nussberger J, Biollaz J, Porchet M, Waeber B, Brunner HR.

Schweiz Med Wochenschr. 1986 Dec 6;116(49):1733-5. French.

PMID:
2949362
17.

Competition of organic anions for furosemide and p-aminohippurate secretion in the rabbit.

Bidiville J, Roch-Ramel F.

J Pharmacol Exp Ther. 1986 May;237(2):636-43.

PMID:
3701646

Supplemental Content

Loading ...
Support Center